Home › IGA Glomerulonephritis › Florida
IGA Glomerulonephritis clinical trials in Florida
13 studies for IGA Glomerulonephritis are looking for participants at sites in Florida.
Cities in Florida
A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Lauderdale Lakes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07902817A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Orlando
- Jade Clinical Site, Pembroke Pines
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Oct 30, 2026 · NCT07541287A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
- Bioresearch Partners, Miami
- Nephrology Associates of South Miami PA, Miami
- BioResearch Partner - Pembroke Pines, Pembroke Pines
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07773727Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- ADARx Clinical Site, Miami
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06989359A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Nova Clinical Research, LLC, Bradenton
- University of Florida - Gainesville - 1600 SW Archer Rd, Gainesville
- Royal Research, Corp., Hollywood
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06935357Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
- Mayo Clinic in Florida, Jacksonville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT06676579A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- Investigator Site #3, Hollywood
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Oct 1, 2026 · NCT06419205Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Univ of Florida Shands Division, Gainesville
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 9, 2026 · NCT06994845Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Nephrology Associates Of Central FL, Orlando
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319Study of WAL0921 in Patients With Glomerular Kidney Diseases
- D & H Tamarac Research Center, Tamarac
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
- Central Florida Kidney Specialists, Orlando
RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Jul 29, 2026 · NCT06797518Study of BHV-1400 in IgA Nephropathy
- Site-003, Miami Lakes
- Site-011, Miami Lakes
- Site-013, Orlando
- and 1 more
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of Miami, Leonard M. Miller School of Medicine, Miami
- Nicklaus Children's Hospital, Miami
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.